Thermo Fisher Scientific

Today, we completed the acquisition of Sanofi’s steriles manufacturing site in Ridgefield, New Jersey, welcoming a world-class team of the site’s more than 200 employees to Thermo Fisher Scientific. This milestone expands our long-standing partnership with Sanofi as, under the agreement, we will continue to manufacture a portfolio of their therapies at this state-of-the-art sterile fill/finish and packaging facility. We will also expand the Ridgefield site’s use to meet the growing demand from pharma and biotech customers for U.S. manufacturing capacity. “We are excited to add Sanofi’s Ridgefield site to our network and welcome more than 200 highly experienced colleagues to Thermo Fisher,” said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher. “Bringing this world-class facility and team into our network strengthens our U.S. manufacturing capabilities to better support pharmaceutical and biotech customers, while positioning us for future expansion."

We have completed the acquisition of Solventum’s Purification & Filtration business. This is an excellent strategic fit and aligns well with our Mission to enable our customers to make the world healthier, cleaner and safer. The business’ advanced filtration technologies bring expanded and differentiated capabilities to our bioprocessing portfolio to better serve the end-to-end needs of pharma and biotech customers, improving quality and efficiency across upstream and downstream workflows. In addition, industrial filtration and membrane solutions extend our reach into adjacent markets, including battery, semiconductor, and medical device manufacturing.

Three of our groundbreaking innovations have secured R&D 100 Awards. All three products are recognized in the Analytical/Test category for their impact on instrumentation, imaging, testing systems, laboratory equipment, and life sciences technologies. 🔬 Stellar™ Mass Spectrometer: Enhances precision medicine with 10x more sensitivity and faster biomarker verification, driving advancements in omics research and biopharmaceutical development. 🧬 KingFisher™ PlasmidPro Maxi Processor: Transforms DNA purification with fully automated, high-purity plasmid preparation in just 75 minutes, speeding up research and reducing contamination risks. 🧫 SteriSEQ™ Rapid Sterility Testing Kit: Uses real-time PCR technology for quick and reliable detection of bacterial and fungal DNA, helping to ensure safer and faster cell therapy delivery. These innovations underscore our commitment to pushing the boundaries of science and helping researchers achieve deeper insights, faster timelines, and safer products. We are honored to be recognized for our contributions to scientific progress and look forward to continuing to support our customers in the discovery and development of treatments that improve lives.

Students like Akari gain confidence and find their voice by participating in STEM activities that can inspire them to become future innovators. Through our nearly decade-long partnership with Boys & Girls Clubs of America, we proudly support Akari and students like her across the U.S. Together, we can provide youth with high-quality STEM learning experiences that unlock their potential and pave the way for future success.

Take a look at 12 amazing images that show how innovations in spatial biology and advanced imaging help scientists see cells more clearly and enable discoveries that will shape the future of medicine, according to Thermo Fisher’s Trisha Dowling. Researchers can now see immune cells and tiny parts of cells as they attack and destroy cancer cells, Dowling shares. This insight helps them understand how certain cancer treatments work and leads to the discovery and development of new therapies. By combining these detailed images with studies of proteins and genes, healthcare providers can one day better predict and evaluate how patients will respond to specific treatments. Explore more at the link in the comments.

State and federal officials joined us for the opening of our new 375,000-square-foot manufacturing center of excellence in Mebane, North Carolina. The site was built in coordination with the federal government to strengthen U.S. supply chain resilience and support research and therapy development for decades to come. During the grand opening, attendees, including North Carolina Governor Joshua Stein, toured the new facility, which is designed for efficiency and with advanced automation. The site can produce 40 million pipette tips per week, ensuring a reliable supply of the tools used for experiments, running tests, and developing new medicines. In addition to this facility, we committed earlier this year to a $2 billion investment in U.S. manufacturing capabilities over the next four years. This includes $1.5 billion for expanding and enhancing manufacturing operations and $500 million for high-impact research and development, creating high-paying jobs, while adding lab services capability and supporting the domestic healthcare supply chain.

We believe every student has the potential to become an innovator and are committed to supporting youth globally to help them reach their potential. Our colleagues play a vital role in this mission. Thanks to their dedication and expertise, we’ve developed initiatives that spark curiosity and ignite a passion for STEM that empowers the future workforce to drive innovation worldwide. Our programs support youth from elementary school to post-secondary success through the Thermo Fisher Scientific Junior Innovators Challenge, a partnership with Society for Science that helps get kids involved in local science fairs, collaborations with the Boys & Girls Clubs of America in our local communities, an apprenticeship program in Cork, Ireland and so much more. Join us to inspire and empower young learners to get involved in STEM.

Our Orbitrap Astral Mass Spectrometer has been awarded the Royal Society of Chemistry's Analytical Science Horizon Prize, which celebrates discoveries and innovations that push the boundaries of science. The Orbitrap Astral “is the most significant technological advancement in mass analysers in two decades,” says Thermo Fisher’s Dr Hamish Stewart. “High sensitivity allows deep investigative studies of single cells that only a few years ago were considered impossible.” This, combined with other technologies, helps researchers to achieve a deeper understanding of disease at the molecular level, which has already led to important discoveries, including new potential treatments. Thank you to our incredible colleagues and partners for your dedication. Together, we are making scientific possibilities a reality.

A big thank you to our colleagues globally for your support of our Healthier Communities initiative! Colleagues from 16 countries volunteered to pack hygiene kits, assemble prosthetic limbs, build care items for pediatric hospital patients and so much more. Their dedication is making a real difference in improving health for people and communities across the globe.